Global CDMO PEGs Solutions
Polyethylene Glycol Manufacturers and Suppliers in India
PEGylated Drugs Manufacturers in India
When global pharmaceutical and biotech companies source high molecular weight PEG, they need more than a supplier — they need a manufacturer they can rely on at scale. As one of the leading and trusted polyethylene glycol PEGs manufacturers in India, Shilpa Pharma delivers exactly that.
Operating from GMP-certified, export-oriented facilities in India, we manufacture pharmaceutical-grade Polyethylene Glycol (PEG 5000 and above), supplying regulated markets across the US, Europe, Japan, UAE, and beyond. Our PEGs are purpose-built for advanced pharmaceutical applications, PEGylation of biologics, drug delivery systems, ADC development, and injectable formulations — where purity, batch consistency, and regulatory compliance are non-negotiable.
Backed by deep expertise in polymer chemistry, scalable manufacturing infrastructure, and approvals from USFDA, EU GMP, and PMDA, we deliver full supply chain confidence with every order. Every batch is supported by comprehensive documentation including Certificate of Analysis (CoA), MSDS, and regulatory dossiers ready for global submissions.
For PEG drug enquiries, mail us at: info@shilpapharma.com.
GMP-Certified | Pharma-Grade | Global Export Ready | MOQ: 1 Ton
Offering Complete Range of Polyethylene Glycol Pharmaceuticals Products
| Sr No. | Category Name | Molecular Weight (Mn) / PDI | Compound Description | Enquire |
|---|---|---|---|---|
| 1 | Various Molecular weights of Methoxy PEG | Mn: 3kDa, 5kDa, 10kDa, 20kDa with low PDI | — | Enquire Now |
| 2 | Poly(2-ethyloxazoline) |
Average Mn: 3500–6500 (PDI ≤1.3), Average Mn: 8500–12500 (PDI ≤1.4), Average Mn: 17500–22500 (PDI ≤1.5) | PEOz is amorphous, water-soluble, stable with temperature | Enquire Now |
| 3 | Monodisperse PEG Diols (PEG6, PEG8, PEG9, PEG12) | 6, 8, 9, 12 kDa with low PDI | — | Enquire Now |
| 4 | Poly(ethylenimine hydrochloride) |
Average Mn: 4000–7000 (PDI ≤1.5), Average Mn: 8000–12000 (PDI ≤1.6), Average Mn: 17000–22000 (PDI ≤1.6) | High charge density, interacts with DNA; used in PEI & PEI-β-mPEG delivery vectors | Enquire Now |
| 5 | Various Molecular weights of Methoxy PEG-block-Poly(ethyleneimine) | Mn: 12, 25 kDa with low PDI | — | Enquire Now |
| 6 | Linear Poly(ethyleneimine) |
Average Mn: 2000–3000 (PDI ≤1.5), Average Mn: 4000–6000 (PDI ≤1.6), Average Mn: 7000–9000 (PDI ≤1.6) | — | Enquire Now |
| 7 | Various Molecular weights of Methoxy PEG-block-Poly(2-ethyloxazoline) | Mn: 8, 20, 40 kDa with low PDI | — | Enquire Now |
| 8 | Poly[2-(dialkylamino)ethyl methacrylate] derivatives | Different derivatives shown (dimethylamino, diethylamino, diisopropylamino) | — | Enquire Now |
| 9 | Various Molecular weights of Methoxy PEG-block-PLGA | Various MW with low PDI | — | Enquire Now |
⚠️ Please Note: Shilpa Pharma currently manufactures PEG 5000 and above only. We are unable to support enquiries for PEG grades below PEG 5000.
Disclaimer
The content on this website is for general informational purposes only. While we strive for accuracy, Shilpa Pharma makes no warranties regarding the completeness, reliability, or suitability of the information. For detailed product specifications, regulatory documentation, or inquiries, please contact us directly.
GLOBAL LEADERS IN PEGs MANUFACTURING FOR PHARMA & BIOMEDICAL APPLICATIONS
At Shilpa Pharma, we specialize in the manufacturing of high-purity Polyethylene Glycols (PEGs) engineered for advanced pharmaceutical and biomedical applications. Here’s why leading global pharma companies partner with us:
Global Regulatory & Quality Compliance
PEGs manufactured in line with international pharmacopeia and regulatory standards for safe global commercialization.
GMP-Certified Manufacturing Excellence
State-of-the-art GMP facilities ensuring consistent quality, scalability, and batch-to-batch reliability.
Specialized PEGs Expertise for Pharma & Biomedicine
Deep expertise in PEG synthesis and functionalization designed specifically for drug delivery, biologics, and biomedical use.
Custom PEG Development & R&D Capabilities
Tailored PEG molecular weights, end-group modifications, and functional PEGs developed to meet complex formulation and conjugation needs.
Trusted Global PEGs Partner
Decades of experience, strong international presence, and long-term partnerships with leading pharmaceutical innovators worldwide.
End-to-End CDMO Support
Comprehensive support from PEG development and scale-up to analytical validation, documentation, and commercialization.
Shilpa Pharma’s Portfolio of Pharmaceutical Polyethylene Glycol Manufacturing
Shilpa Pharma offers a comprehensive portfolio of pharmaceutical-grade Polyethylene Glycols (PEGs) engineered to support advanced drug delivery, biologics, and biomedical applications. With strong scientific expertise and robust manufacturing capabilities, we deliver high-purity PEG solutions designed to meet the evolving needs of global pharmaceutical innovators.
Our portfolio includes a wide range of Methoxy PEGs (mPEGs) across multiple molecular weights, PEG diols, and functionalized PEG derivatives developed for precision conjugation and formulation flexibility. We also manufacture PEGylated linkers and activated PEGs that enable effective PEGylation of peptides, proteins, and small molecules, improving solubility, stability, and therapeutic performance.
In addition to standard PEG grades, Shilpa Pharma provides custom PEG synthesis and functionalization, including block copolymers and specialized linker chemistries, supporting research, clinical development, and commercial manufacturing.
All PEG products are manufactured in GMP-compliant facilities and adhere to stringent quality standards. Our operations are accredited by major international regulatory authorities, including USFDA, EU GMP, ANVISA, COFEPRIS, TGA, PMDA, and KFDA, ensuring global acceptance and regulatory confidence.
Driven by innovation, quality, and reliability, Shilpa Pharma remains a trusted global partner for pharmaceutical PEG manufacturing.
Applications of High Molecular Weight PEG
High molecular weight PEGs (5000 Da and above) are a critical material in modern pharmaceutical and biotech manufacturing. Shilpa Pharma’s PEG grades are used across a wide range of advanced applications:
- Pharmaceutical & Drug Formulation PEG is widely used as an excipient, binder, and coating agent in solid dosage forms. High-MW grades improve tablet integrity, control drug release, and enhance the stability of injectable formulations. PEG also serves as a base for ointments and suppositories in topical and transdermal drug products.
- PEGylation of Biologics PEGylation — the attachment of PEG chains to proteins, peptides, or antibodies — is one of the most critical applications of high molecular weight PEG. It extends the half-life of therapeutic proteins, reduces immunogenicity, and improves pharmacokinetic profiles. Our high-purity PEG 5000 and above grades are ideally suited for this purpose.
- Antibody-Drug Conjugates (ADC) In ADC development, PEG linkers play a key role in improving the solubility and stability of the conjugate while ensuring controlled payload release at the target site. Shilpa Pharma’s PEG grades support precise bioconjugation chemistry required in next-generation ADC therapeutics.
- Drug Delivery Systems High molecular weight PEGs are extensively used in nanoparticle surface coating, liposomal drug delivery, and polymeric micelle formulations. These systems improve drug bioavailability, extend circulation time, and enable targeted delivery to specific tissues.
- Controlled & Sustained Release Formulations PEG matrices are used to design controlled-release drug products, allowing for predictable, sustained drug release over time — improving patient compliance and therapeutic outcomes.
- Biotech & Research Applications High-MW PEG is used in protein crystallization, cell fusion studies, bioseparation processes, and as a crowding agent in biochemical assays. It is also a key component in hydrogel systems used for tissue engineering and regenerative medicine.
Explore Our Other Product Range
Get in Touch: Your Trusted Partner in PEGs Manufacturing
Get a Quote
Happy Customers
Projects Successfully Completed
Established
PhD Experts Driving R&D Excellence
Team Size
World-Class API Manufacturing Sites
Global Audits Successfully Completed
Comprehensive CDMO Service Offerings
Questions & Answers
Our FAQ's
Everything You Need to Know About PEGs development in India at Shilpa Pharma
What are PEGs and why are they important in pharmaceuticals?
Polyethylene Glycols (PEGs) are widely used in pharmaceuticals to improve solubility, stability, bioavailability, and half-life of drugs, especially in biologics and advanced drug delivery systems.
Why choose Shilpa Pharma for PEGs development in India?
Shilpa Pharma combines deep polymer science expertise, cGMP-compliant manufacturing, advanced analytics, and global regulatory approvals, making it a trusted partner for pharmaceutical-grade PEG development.
Does Shilpa Pharma offer custom PEG development?
Yes, we provide customized PEG synthesis, molecular weight control, functionalization, and PEGylation-ready derivatives to meet specific formulation and conjugation requirements.
What types of PEGs are developed at Shilpa Pharma?
Our portfolio includes mPEGs, PEG diols, functionalized PEGs, PEG linkers, activated PEGs, and specialized PEG derivatives for drug delivery and biomedical applications.
Are Shilpa Pharma’s PEGs manufactured under regulatory-compliant conditions?
All PEGs are produced in cGMP facilities accredited by major global authorities, ensuring suitability for regulated markets and commercial pharmaceutical use.
Does Shilpa Pharma support PEGs scale-up and commercialization?
Yes, we support the complete lifecycle—from lab-scale development and process optimization to large-scale manufacturing and commercial supply.
Can Shilpa Pharma support PEGylation and drug conjugation projects?
Absolutely. We offer PEGs designed for PEGylation and conjugation, helping enhance drug performance, stability, and therapeutic efficacy.
Which industries benefit from PEGs developed at Shilpa Pharma?
Our PEG solutions support pharmaceutical, biotech, biomedical, and advanced drug delivery industries across global markets.
What CDMO services does Shilpa Pharma offer for PEGs manufacturing?
Shilpa Pharma provides end-to-end CDMO services, including PEG design, process development, scale-up, GMP manufacturing, analytical testing, and regulatory documentation support.
Can Shilpa Pharma support early-stage and late-stage PEGs programs?
Yes, we support PEGs projects across all stages—from early research and preclinical development to clinical supply and commercial-scale manufacturing.
How does Shilpa Pharma ensure quality and consistency in CDMO PEGs manufacturing?
We follow robust quality systems, validated processes, advanced analytical controls, and strict GMP compliance to ensure batch-to-batch consistency.
Does Shilpa Pharma offer confidential and IP-protected PEGs development?
Absolutely. All CDMO engagements follow strict confidentiality agreements and IP protection frameworks to safeguard client innovations.
Can Shilpa Pharma handle complex and customized PEGs at scale?
Yes, our strong process chemistry expertise and scalable manufacturing infrastructure enable reliable production of complex and highly specialized PEGs for global markets.
Countries We Serve in
Learn About Polyethylene Glycols
Polyethylene Glycol Manufacturers in India | Shilpa Pharma
In the growing chemical and pharmaceutical sectors, polyethylene glycol (PEG) plays a critical role in applications ranging from drug formulation to cosmetics and industrial processes. As demand for high-quality PEG increases, businesses are actively seeking reliable polyethylene glycol manufacturers in India who can meet global quality standards, ensure supply consistency, and offer competitive pricing.
Shilpa Pharma is among the leading PEG manufacturers in India, known for its strong manufacturing capabilities, stringent quality control, and customer-centric approach. We produce a wide range of polyethylene glycol grades that comply with pharmacopoeial standards (IP, BP, USP), making them suitable for both pharmaceutical and industrial use.
As experienced polyethylene glycol suppliers, we understand the critical needs of B2B clients—timely deliveries, consistent batch quality, regulatory documentation, and technical support. Our modern manufacturing facilities and commitment to innovation make Shilpa Pharma a preferred partner for businesses across sectors.
If you’re sourcing from polyethylene glycol manufacturers for bulk or contract supply, Shilpa Pharma offers a reliable, scalable, and quality-assured solution.
What is Polyethylene Glycol?
Polyethylene Glycol (PEG) is a polyether compound widely used across various industries for its versatility, solubility, and low toxicity. It is produced through the polymerization of ethylene oxide and is available in a range of molecular weights, which determines its physical form (liquid, semi-solid, or solid) and application.
In the pharmaceutical and healthcare industries, PEG is commonly used as a solvent, binder, and drug delivery agent. It enhances the solubility and bioavailability of active pharmaceutical ingredients (APIs), making it a key excipient in tablets, ointments, and injectable formulations.
Common Applications of PEG:
- Pharmaceutical formulations (laxatives, ointments, tablets)
- Personal care products (moisturizers, shampoos)
- Industrial uses (lubricants, coatings, surfactants)
- Food processing (as anti-foaming or coating agents)
Global Regulatory Approvals and Compliance
As a globally recognized Polyethylene Glycol supplier in India, Shilpa’s manufacturing facilities meet the highest international quality standards. The company holds approvals and certifications from several major regulatory bodies, ensuring consistent product quality and regulatory compliance.
Our facilities are:
- USFDA Approved (United States Food & Drug Administration)
- EU GMP Certified (European Union Good Manufacturing Practice)
- ANVISA Approved (Brazilian Health Regulatory Agency)
- COFEPRIS Approved (Mexico)
- TGA Certified (Australia)
- PMDA Approved (Japan)
- KFDA Certified (South Korea)
These certifications position Shilpa Pharma as a trusted partner for both regulated and semi-regulated markets.
Why Choose Shilpa PEGs Manufacturing in India?
When sourcing high-quality polyethylene glycols (PEGs), global businesses prioritize reliability, compliance, and consistency. Shilpa Pharma has established itself as a leading name in PEG manufacturing in India, combining technical expertise with strong manufacturing capabilities as a trusted Contract Development and Manufacturing Organization (CDMO).
- GMP-Certified Manufacturing Our facilities are fully GMP-compliant and have received regulatory approvals from the USFDA, EU GMP, and PMDA (Japan). Every batch of PEG is manufactured under stringent quality protocols to ensure consistency, purity, and safety.
- High Molecular Weight Specialization Unlike generalist chemical suppliers, Shilpa Pharma focuses exclusively on high molecular weight PEG grades (5000 Da and above). This specialization means deeper process expertise, tighter quality controls, and more consistent output for demanding pharmaceutical applications.
- Scalable Supply from 1 Ton Upwards With a minimum order quantity of 1 metric ton and the capacity to fulfill large commercial volumes, we support clients across clinical-stage development, scale-up, and full commercial manufacturing without supply disruption.
- Export-Oriented, India-Based Manufacturing As a 100% export-oriented unit based in India, we combine cost-effective production with world-class infrastructure — giving global buyers a distinct advantage in sourcing high-quality PEG at competitive value.
- Comprehensive Regulatory Documentation We provide complete documentation support including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Drug Master File (DMF) assistance, and submission-ready regulatory dossiers for international markets including US, EU, and Japan.
- Trusted by Global Partners Shilpa Pharma supplies to pharmaceutical and biotech companies across the United States, Germany, France, United Kingdom, Japan, China, Singapore, UAE, South Korea, Brazil, Australia, and more. Our track record of long-term partnerships reflects our commitment to quality and reliability.
- End-to-End Support From initial enquiry and sample supply to bulk orders and documentation — our technical and commercial teams are responsive, knowledgeable, and committed to making your sourcing experience seamless.
Proven CDMO Capabilities
As an experienced CDMO, Shilpa Pharma partners with pharmaceutical, cosmetic, and industrial clients to deliver customized PEG solutions. From development to commercial production, our team supports clients through every stage, ensuring that formulations meet both functional needs and regulatory standards.
Our CDMO services include:
Custom PEG formulation and grade development
Scale-up from pilot to commercial batches
Regulatory support and documentation
Quality control aligned with USP, BP, IP standards
We go beyond manufacturing — we act as a strategic partner invested in your product’s success.
Trusted by Global Markets
Shilpa Pharma is the preferred PEG supplier for companies across China, Japan, Europe, and other international markets. This global trust is built on our consistent product quality, robust compliance framework, and responsive customer service.
Why international clients choose Shilpa Pharma:
High-purity PEGs for pharmaceutical and industrial use
Consistent quality and documentation
Scalable production capacity
On-time delivery and global logistics support
Our track record of international partnerships reflects our commitment to excellence and reliability.
Manufacturing Strength in India
Operating from India, Shilpa Pharma combines cost-effective manufacturing with state-of-the-art infrastructure. Our facilities are GMP-compliant and equipped to handle diverse molecular weights and specifications of polyethylene glycol, offering flexibility for both small and large-scale orders.
